Trial Profile
OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277 in Patients Who Have Completed Study 901 and Study 910 (Extension to 901 Phase III Study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Peptide p277 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 27 Jun 2016 New trial record